Search research articles
Contact Us
Filters
Showing results (131-140 of 177) with videos related to
Page
of 18
Sort By:
Molecular and Cellular Biology
|
January 27, 2016
Type I Interferons Control Proliferation and Function of the Intestinal Epithelium
Yuliya V Katlinskaya, Kanstantsin V Katlinski, Audrey Lasri, et al.
Nature Cancer
|
April 15, 2025
Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors
Wenqun Zhong, Zhiyuan Qin, Ziyan Yu, et al.
The American Journal of Pathology
|
November 13, 2013
HCV infection selectively impairs type I but not type III IFN signaling
Partha K Chandra, Lili Bao, Kyoungsub Song, et al.
Cell Reports
|
April 8, 2016
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
Yuliya V Katlinskaya, Kanstantsin V Katlinski, Qiujing Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 1997
Conformation-dependent phosphorylation of p53
V Adler, M R Pincus, T Minamoto, et al.
The Journal of Clinical Investigation
|
May 27, 2015
ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis
Souvik Dey, Carly M Sayers, Ioannis I Verginadis, et al.
Cell Reports
|
April 30, 2015
DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function
Qiujing Yu, Yuliya V Katlinskaya, Christopher J Carbone, et al.
Nature Cell Biology
|
April 15, 2020
Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling
Snahlata Singh, Sushil Kumar, Ratnesh Kumar Srivastava, et al.
Molecular and Cellular Biology
|
April 3, 2001
Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress
T Buschmann, O Potapova, A Bar-Shira, et al.
Plos Genetics
|
December 16, 2016
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma
Dariusz Pytel, Yan Gao, Katarzyna Mackiewicz, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 177) with videos related to
Sort By:
Page
of 18
Molecular and Cellular Biology
|
January 27, 2016
Type I Interferons Control Proliferation and Function of the Intestinal Epithelium
Yuliya V Katlinskaya, Kanstantsin V Katlinski, Audrey Lasri, et al.
Nature Cancer
|
April 15, 2025
Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors
Wenqun Zhong, Zhiyuan Qin, Ziyan Yu, et al.
The American Journal of Pathology
|
November 13, 2013
HCV infection selectively impairs type I but not type III IFN signaling
Partha K Chandra, Lili Bao, Kyoungsub Song, et al.
Cell Reports
|
April 8, 2016
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
Yuliya V Katlinskaya, Kanstantsin V Katlinski, Qiujing Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 1997
Conformation-dependent phosphorylation of p53
V Adler, M R Pincus, T Minamoto, et al.
The Journal of Clinical Investigation
|
May 27, 2015
ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis
Souvik Dey, Carly M Sayers, Ioannis I Verginadis, et al.
Cell Reports
|
April 30, 2015
DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function
Qiujing Yu, Yuliya V Katlinskaya, Christopher J Carbone, et al.
Nature Cell Biology
|
April 15, 2020
Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling
Snahlata Singh, Sushil Kumar, Ratnesh Kumar Srivastava, et al.
Molecular and Cellular Biology
|
April 3, 2001
Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress
T Buschmann, O Potapova, A Bar-Shira, et al.
Plos Genetics
|
December 16, 2016
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma
Dariusz Pytel, Yan Gao, Katarzyna Mackiewicz, et al.
Page
of 18